Similarly, tumor infiltrating CD8+ T cells from mice treated with the above combination therapy displayed higher efficacy in killing a colon cancer cell line, MC-38, most likely due to the increase in granzyme B expression (76). This evidence concerns the gene CD8A and neoplasm.